F3M:FRA
Tempus AI Inc
€66.48
arrow_downward
-0.89%(-0.60) 1D
Sep 24, 8:02:44 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for F3M...
Open
€66.48
High
€66.48
Low
€66.48
Mkt. cap
13.82B
Avg. vol.
1.02K
Volume
0.00
52-wk high
€90.00
52-wk low
€35.79
No. of employees
4K
Open
€66.48
High
€66.48
Low
€66.48
Mkt. cap
13.82B
Avg. vol.
1.02K
Volume
0.00
52-wk high
€90.00
52-wk low
€35.79
No. of employees
4K
News stories
From web sources and news partners
Investing.com
·
7 hours ago
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics
Seeking Alpha
·
1 day ago
Tempus AI: High Risk, But With A Great Cause (NASDAQ:TEM)
Seeking Alpha
·
2 days ago
Tempus AI: Data And Applications Will Unlock More Upside (NASDAQ:TEM)
Yahoo Finance
·
2 days ago
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
Profile
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia
About Tempus AI Inc
CEOEric Lefkofsky
Employees3.8K
Founded2015
HeadquartersChicago, Illinois, United States
SectorHealth care
Websitetempus.com